Cemag Invest

Cemag Invest is a family office established in 2016, focusing on minority capital development investments in healthcare, B2B services, and technology sectors across Europe. The firm aims to support innovative companies with high growth potential, providing them with the necessary resources and expertise to scale their operations. Cemag Invest collaborates with institutional investors to co-invest in promising startups, ensuring a diversified and robust investment portfolio.

The firm's investment strategy emphasizes early-stage and growth-stage companies, particularly those in the seed and early stages of development. By targeting these stages, Cemag Invest seeks to identify and nurture startups that can achieve significant market impact. The geographical focus includes various European countries, with a particular emphasis on France, Germany, the United Kingdom, and other key European markets. This regional focus allows the firm to leverage its local expertise and networks to support portfolio companies effectively.

Cemag Invest's portfolio includes investments in sectors such as healthcare, B2B services, and technology. The firm has a history of supporting companies like Diabeloop, a French health-tech company specializing in diabetes management solutions. By providing strategic guidance and capital, Cemag Invest plays a crucial role in the growth and success of its portfolio companies, contributing to the advancement of innovative solutions in its target industries.